The Discounted Cash Flow (DCF) valuation of Theradiag SA (ALTER.PA) is (2.25) EUR. With the latest stock price at 1.26 EUR, the upside of Theradiag SA based on DCF is -278.6%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 6.4% | 5.7% |
| Long-term Growth Rate | 3.0% - 4.7% | 3.9% |
| Fair Price | (18.24) - (1.09) | (2.25) |
| Upside | -1547.3% - -186.6% | -278.6% |